Estuardo Aguilar-Cordova - 21 Feb 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Feb 2025, 13:35:32 UTC
Prior SEC filing
13 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Estuardo Aguilar-Cordova

Key filing fact

Estuardo Aguilar-Cordova filed Form 4 for Candel Therapeutics, Inc. (CADL) on 25 Feb 2025.

Key facts

  • This page summarizes Estuardo Aguilar-Cordova's Form 4 filing for Candel Therapeutics, Inc. (CADL).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Feb 2025, 13:35.

Change

  • Previous filing in this sequence was filed on 13 Feb 2025.
  • Current net transaction value: -$254,403.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CADL transaction

CADL

Disposed to Issuer

Transaction value
$127,196
Shares
-10,582
Change %
-8.1%
Price
$12.02
Shares after
120,861
Date
21 Feb 2025
Ownership
By LKA 2022 Revocable Trust
Footnotes
F1
CADL transaction

CADL

Disposed to Issuer

Transaction value
$127,208
Shares
-10,583
Change %
-6.1%
Price
$12.02
Shares after
162,929
Date
21 Feb 2025
Ownership
Direct
CADL holding

CADL

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,013,100
Date
21 Feb 2025
Ownership
Laura K. Aguilar 2020 Irrevocable Trust
Footnotes
F2
CADL holding

CADL

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,074,942
Date
21 Feb 2025
Ownership
By Estuardo Aguilar-Cordova 2020 Irrevocable Trust
CADL holding

CADL

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
60,000
Date
21 Feb 2025
Ownership
Direct
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares of common stock held by spouse LKA 2022 Revocable trust

Footnote F2

Shares of common stock held by spouse irrevocable trust

Footnote F3

Shares of common stock held jointly with spouse

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .